64 results about "Prostatic disease" patented technology

The present invention discloses a purification method of rape broken pollen and a prepared extract. The purification method includes using macroporous resin to accumulate the extract of rape broken pollen extracted by supercritical carbon dioxide, adopting ethanol for elution and collecting the eluent. The present invention is simple in the method and easy in operation. The extracted effective components have good anti-inflammatory activity and efficacy of resisting prostatic hyperplasia, prostatic fibrosis and other prostatic diseases.

A compound represented by formula (I); wherein ring A represents a nitrogen containing heterocyclic ring, ring B represents 5-membered heterocyclic ring which may have substituents, R represents a hydrogen atom or cyano and the other symbols represent as described in the specification; or a salt thereof. The compound represented by formula (I) has an inhibitory activity of DPP-IV, and therefore is useful as a preventive and / or treatment agent for type 2 diabetes mellitus, obesity, autoimmune disease, cancer metastasis, AIDS virus infection, dermatosis, prostatic hypertrophy and the like

An application of common bamboo leaf flavone in preparing the medicines or health-care food for preventing and treating prostatic diseases is disclosed. Its advantages are sure curative effect, refreshing smell, agreeable taste, and no by-effect.

The invention discloses food prepared by quick-oil-boiling amorphophallus konjac with phytosterol and a preparation method of the food. A variety of nutritious amorphophallus konjac food which is fragrant and delicious can be prepared by quick-oil-boiling preliminarily-processed amorphophallus konjac with the phytosterol, wherein alkaloid is broken, the peculiar smell is eliminated, and the fragrance is generated. The phytosterol is generally recognized as a vascular scavenger, is a good medicine for lowering in-vivo cholesterol, repairing tissues and suppressing tumors, and also is a new resource food or healthy food supplement published in China, Europe, America, Japan and the like. The amorphophallus konjac contains rich glucomannan, is famous weight-reducing food, and has the reputation of a gastrointestinal cleaner. The combined food of the phytosterol and the amorphophallus konjac has synergetic effects on health care, and is purely natural food without additives; food therapy and health maintenance effects are enhanced by multiple times; diseases such as hypertension, hyperlipidemia, diabetes mellitus, cardiovascular and cerebrovascular diseases, obesity, gall stones, tumors, constipation and prostatic diseases can be prevented or relieved. The fried amorphophallus konjac is used for producing instant amorphophallus konjac strips (chips or powder) or composite amorphophallus konjac food such as amorphophallus konjac milky tea for weight losing and amorphophallus konjac fagopyrum tararicum soup for regulating blood sugar.

The invention discloses an externally-applied traditional Chinese medicine for treating prostatic diseases. The medicine comprises two independent composing prescriptions which are alternately applied, wherein the first composing prescription comprises radix angelica sinensis, cowherb seed, woodwardia japonica, morinda root, epimedium, dodder, prepared rhizoma cyperi, monkshood, Chinese mugwort leaf, fennel, cinnamon, eupatorium, evodia, pinellia tuber, dried orange peel, cortex moutan, peach seed, rhizoma corydalis, lindera aggregata, rhubarb, rhizoma sparganii, zedoary, fenugreek, suberect spatholobus stem, leonurus, borneol and white spirit; the second composing prescription comprises golden cypress, sophora flavescens, patrinia, sargentg loryvine stem, rhubarb, mirabilite, red sage root, safflower, plantain herb, corrugated paper, lychee seed, toosendan fruit, ground beetle, jackinthepulpit tuber, bupleurum, snakegourd fruit, achyranthes bidentata, grass leaved sweetflag, sapanwood, areca peel, pangolin, gleditsia sinensis sting, coptis, loofah sponge, cape jasmine fruit, rhizoma cimicifugae, Sichuan pepper, ginseng and a proper amount of white spirit. The medicine disclosed by the invention has the beneficial effects that the medicine per se has a good treatment effect and is short in pathway of reaching lesion; the stimulation of the medicine on intestines and stomach is avoided; a novel way is developed for treating the prostatic diseases.

A Chinese medicine for treating prostatism is prepared from 18 Chinese-medicinal materials including dandelion herb, epimedium, dodder seed, astragalus root, etc. Its preparing process is also disclosed.

The invention provides an extract of total flavonoids of coromandel coast falsemallow. The weight percent content of the total flavonoids is no less than 1% by taking the weight percent of rutin as a reference. The invention further provides a preparation method and an application of the extract. The extract is stable and controllable in quality as well as simple and feasible in extraction process and cannot perform pollution on the environment, thereby being suitable for large-scale extraction. The extract is used for treating prostatic diseases, and particularly has definite and safe medicinal effects for treating prostatic hyperplasia, prostatitis, prostatic cancers and abacterial prostatitis, thereby providing a new medicine selection for clinical applications.

The invention relates to a medicament for treating a prostatic disease, which is prepared from the following Chinese medical herbs in parts by weight: 40-60 parts of rehmanniae praeparatum, 40-60 parts of rehmanniae vaporata, 50-70 parts of common macrocarpium fruit, 40-60 parts of epimedium, 40-60 parts of morindae, 40-60 parts of desertliving cistanche, 40-60 parts of south dodder seed, 40-60 parts of malaytea scurfpea fruit, 40-60 parts of common cnidium fruit, 40-60 parts of palmleaf raspberry fruit, 30-50 parts of Chinese magnoliavine fruit, 20-40 parts of cassia bark, 30-50 parts of fennel fruit, 30-50 parts of cervus nippon temminck, 30-50 parts of eucommia bark, 30-50 parts of achyranthes root, 30-50 parts of Indian buead, 30-50 parts of dioscoreae, 30-50 parts of Chinese eaglewood, 40-60 parts of dendrobium, 40-60 parts of scrophularia, 30-50 parts of cluster mallow fruit, 40-60 parts of herba pyrrosiae, 40-60 parts of plantago seed, 40-60 parts of rhizoma anemarrhenae, 40-60parts of phellodendron, 40-60 parts of white paeony root and 30-50 parts of raw liquorice root, and capsules are prepared by the steps of grinding the Chinese medical herbs into fine powder and encapsuling. The medicament has effects of invigorating yin, supporting yang, resuscitating and treating stranguria and is mainly suitable for chronic prostatitis or prostatic hyperplasia.

The invention discloses a medicine for treating prostatic diseases and a preparation method thereof. The medicine for treating prostatic diseases is prepared from the following raw materials in parts by weight: 4-6 parts of calculus bovis factitius, 7-9 parts of actinolite, 8-12 parts of fructus cnidii, 4-6 parts of herba epimedii, 4-6 parts of sulphur, 2-4 parts of centipedes, 10-14 parts of cynomorium songaricum, 10-14 parts of eucommia ulmoides, 13-17 parts of salviae miltiorrhizae, 2-4 parts of sculellaria barbata, 8-12 parts of rhizoma sparganii, 7-9 parts of morinda officinalis and 8-12 parts of fish poison yam. The preparation method comprises the following steps: respectively smashing the raw materials, screening by virtue of a 40-80-mesh sieve, and uniformly mixing. The medicine disclosed by the invention has the effects of activating blood circulation and dissipating blood stasis as well as relieving swelling and pain, can be used for treating prostatic diseases, such as acute and chronic prostatitis, prostatic swelling, prostatic hyperplasia and cyst of prostate, and has the advantages of short treatment course, high effect taking speed, good treatment effect, less recurrence, high effective rate, no toxic or side effect, safety and reliability, simplicity in preparation method and convenience in application. In 413 clinical treatment cases, the total effective rate is 96%.